Stocks · Health care · Pharmaceutical Preparations

LIGAND PHARMACEUTICALS INC

LGND Clue Score50
United States Fiscal year ends December CIK 0000886163 Results filed 29 Oct 2026

What the insiders did Net selling

By person

10 insiders · 19 transactions
88.2×

Todd C. Davis holds 88.2 times base salary in stock. $63.93M of shares against $724.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Todd C. Davis last reported holding, valued at $320.43, the price Common Stock was last bought or sold at on the open market here, on 2 Nov 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Andrew Reardon
CLO & Secretary
—
$1.57M (13) scheduled
−$1.57M
31,854
0.1598%
$10.21M
+47.1%
Jason Aryeh
Director
—
$676.16K (6)
−$676.16K
116,758
0.5857%
$37.41M
−10.0%
Todd C Davis
Chief Executive Officer
—
—
—
199,513
1.00%
$63.93M
+62.2%
John W Kozarich
Director
—
—
—
42,622
0.2138%
$13.66M
−2.6%
Stephen L Sabba
Director
—
—
—
33,629
0.1687%
$10.78M
+11.4%
Octavio Espinoza
Chief Financial Officer
—
—
—
27,696
0.1389%
$8.87M
+5.0%
John L Lamattina
Director
—
—
—
26,969
0.1353%
$8.64M
−8.6%
Nancy Ryan Gray
Director
—
—
—
8,930
0.0448%
$2.86M
+29.7%
Jason Haas
Director
—
—
—
3,981
0.0200%
$1.28M
−26.2%
Martine Zimmermann
Director
—
—
—
3,782
0.0190%
$1.21M
+6.9%